bioAffinity Technologies, Inc. (BIAFW) Stock Overview
Explore bioAffinity Technologies, Inc.’s financial performance, market position, analyst ratings, and future outlook.
bioAffinity Technologies, Inc. (BIAFW)
Key Financials
Key Financials
Market Cap
707.6K
P/E Ratio
-0.45
EPS (TTM)
N/A
ROE
-3.59%
BIAFW Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of bioAffinity Technologies, Inc. (BIAFW) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 42.32, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.09.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.45 and a market capitalization of 707.6K. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.